NormOxys

NormOxys, Inc. is a biopharmaceutical company. It provides proprietary products that modulate the binding affinity between oxygen and hemoglobin. NormOxys, Inc. was formerly known as Oxyplus, Inc. and changed its name to NormOxys, Inc. in October 2008. The company was founded in 2003.